FDA recall Z-2211-2023

Ascensia Diabetes Care US, Inc. · Class II · device

Product

Contour¿ next GEN Blood Glucose Monitoring System

Reason for recall

Ascensia Diabetes Care has determined through customer complaints that 580 of 2900 meters from lot number DM01T033P are reconfigured from mg/dL to mmol/L. Among them, 579 meters distributed in the United States were packaged into the meter kit and had incorrect factory-set unit of measure where the meters display glucose results in mmol/L rather than mg/dL. The standard unit of measurement for the United States is mg/dL. If a consumer does not notice the incorrect unit of measurement, it is possible that the meters glucose measurement will be read as a lower blood glucose measurement than expected, and this may result in the patients glucose level remaining high, which can potentially lead to an injury requiring immediate medical intervention.

Distribution

Domestic: CA, CO, FL, IN, MO, NJ, NY, OH, RI, SC, TN, TX, & VA.

Key facts

Status
Ongoing
Initiation date
2023-05-19
Report date
2023-07-26
Voluntary/Mandated
Voluntary: Firm initiated
Location
Valhalla, NY, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-2211-2023